Advertisement
Advertisement
U.S. markets open in 1 hour 4 minutes
S&P Futures
3,925.00 +21.25 (+0.54%) Dow Futures
31,594.00 +173.00 (+0.55%) Nasdaq Futures
12,096.25 +55.75 (+0.46%) Russell 2000 Futures
1,782.10 +12.30 (+0.69%) Crude Oil
111.29 +1.72 (+1.57%) Gold
1,825.50 +0.70 (+0.04%)
Catalent, Inc. (CTLT)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:03PM EDT
After hours:
Advertisement
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Performance Outlook
| Previous Close | 109.61 |
| Open | 110.12 |
| Bid | 0.00 x 900 |
| Ask | 0.00 x 1000 |
| Day's Range | 108.13 - 111.79 |
| 52 Week Range | 86.34 - 142.64 |
| Volume | |
| Avg. Volume | 1,260,927 |
| Market Cap | 19.869B |
| Beta (5Y Monthly) | 1.43 |
| PE Ratio (TTM) | 40.05 |
| EPS (TTM) | 2.77 |
| Earnings Date | Aug 29, 2022 - Sep 02, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 138.15 |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-11% Est. Return
Subscribe to Yahoo Finance Plus to view Fair Value for CTLT
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
- Catalent, Inc.Analyst Report: Catalent, Inc.Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenues primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products throughout the entire life cycle of a product from the drug development process to commercial supply. Catalent has over 50 facilities across four continents.RatingFair ValueEconomic Moat14 hours agoMorningstar
- Zacks
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- Yahoo Finance
Health authorities push for a vaccine patent waiver to 'genuinely' prepare for the next pandemic
The World Trade Organization is meeting this week to consider adopting an agreement that would make it easier to produce COVID-19 vaccines and treatments by waiving patent enforcement during health emergencies.
- Zacks
Catalent (CTLT) Inks Deal With MigVax for Oral COVID-19 Vaccine
Catalent's (CTLT) latest agreement is expected to significantly boost global COVID-19 vaccination drives.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2022 Yahoo. All rights reserved.
